Inventor · disambiguated record
Jack A. Elias
Also filed as: ELIAS JACK · ELIAS JACK A
15 granted patents·27 pending applications·46 citations·filing 2002–2023
90Inventor score
Top patents by PatentIndex Score
42 records- 0195US10253111B2Methods and compositions relating to anti-Chi3l1 antibody reagentsUNIV BROWN·Filed 2018·Granted Apr 9, 2019·12 cites·14 claims
- 0292US8182814B2Methods of treating inflammatory airway conditions by inhibition of IL-11 activityBACA MANUEL·Filed 2008·Granted May 22, 2012·22 cites·16 claims
- 0390US10766968B2Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancerUNIV BROWN·Filed 2018·Granted Sep 8, 2020·5 cites·8 claims
- 0480US2023406958A1Methods and compositions relating to anti-chi3l1 antibody reagentsUNIV BROWN·Filed 2023·Application pending·0 cites
- 0577US10752700B2Methods and compositions relating to anti-CHI3L1 antibody reagents to treat nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease (NFALD) or metabolic syndromeUNIV BROWN·Filed 2018·Granted Aug 25, 2020·1 cites·10 claims
- 0675US8642357B2Semaphorin 7A plays a critical role in TGF-β1-induced pulmonary fibrosis and alveolar destructionELIAS JACK A·Filed 2009·Granted Feb 4, 2014·1 cites·15 claims
- 0773US11717528B2Methods and compositions relating to the treatment of fibrosisUNIV BROWN·Filed 2022·Granted Aug 8, 2023·0 cites·5 claims
- 0870US11667725B2Methods and compositions relating to anti-CHI3L1 antibody reagents for the treatment of cancerUNIV BROWN·Filed 2020·Granted Jun 6, 2023·0 cites·15 claims
- 0969US7214373B2Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory diseaseUNIV YALE·Filed 2002·Granted May 8, 2007·3 cites·5 claims
- 1066US7943130B2Methods and compositions relating to CCR5 antagonist, IFN-γ and IL-13 induced inflammationUNIV YALE·Filed 2004·Granted May 17, 2011·2 cites·13 claims
- 1165US11667726B2Methods and compositions relating to bispecific anti-CHI3L1 antibody reagents for the treatment of cancerUNIV BROWN·Filed 2020·Granted Jun 6, 2023·0 cites·16 claims
- 1264US2024076407A1Methods and compositions relating to bispecific anti-chi3l1 antibody reagentsUNIV BROWN·Filed 2023·Application pending·0 cites
- 1364US2009162347A1Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory diseaseUNIV YALE·Filed 2008·Application pending·0 cites
- 1463US2009149410A1Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory diseaseUNIV YALE·Filed 2008·Application pending·0 cites
- 1563US2009148539A1Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory diseaseUNIV YALE·Filed 2008·Application pending·0 cites
- 1662US11478530B2Methods for decreasing chord lengthUNIV BROWN·Filed 2018·Granted Oct 25, 2022·0 cites·2 claims
- 1761US2023312752A1Methods for preventing, reversing or treating an infection induced by a virus that enters host cells via ace2 receptorUNIV BROWN·Filed 2022·Application pending·0 cites
- 1858US11219630B2Methods and compositions relating to the treatment of fibrosisUNIV BROWN·Filed 2018·Granted Jan 11, 2022·0 cites·3 claims
- 1958US2011059100A1C/CLP Antagonists And Methods Of Use ThereofMEDIMMUNE LLC·Filed 2009·Application pending·0 cites
- 2057US2011177963A1Variation in the CHI3L1 Gene Influences Serum YKL-40 Levels, Asthma Risk and Lung FunctionYALE UNVERSITY·Filed 2008·Application pending·0 cites
- 2157US2006063728A1Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory diseaseUNIV YALE·Filed 2004·Application pending·0 cites
- 2255US2006074066A1Use of an inhibitor of cathepsin-S or -B to treat or prevent chronic obstructive pulmonary diseaseUNIV YALE·Filed 2005·Application pending·0 cites
- 2355US2006030562A1Use of an inhibitor of cathepsin-S-or-B to treat or prevent chronic obstructive pulmonary diseaseUNIV YALE·Filed 2005·Application pending·0 cites
- 2454US2014200184A1Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney InjuryUNIV YALE·Filed 2014·Application pending·0 cites
- 2553US9994905B2Methods for the diagnosis and treatment of pulmonary fibrosis in subjects with hermansky pudlak syndromeUNIV BROWN·Filed 2015·Granted Jun 12, 2018·0 cites·17 claims
- 2653US2023183323A1Methods for preventing, reversing or treating a covid-19 infectionUNIV BROWN·Filed 2021·Application pending·0 cites
- 2752US2007071746A1C/CLP antagonists and methods of use thereofMEDIMMUNE INC·Filed 2006·Application pending·0 cites
- 2851US8679503B2Methods, compositions and kits relating to chitnases and chitnase-like molecules and inflammation diseaseELIAS JACK A·Filed 2010·Granted Mar 25, 2014·0 cites·8 claims
- 2951US2023046834A1Bispecific antibodies against chi3l1 and ctla4 with enhanced cytotoxic effects on tumor cellsUNIV BROWN·Filed 2020·Application pending·0 cites
- 3050US8221988B2Methods and compositions relating to CCR5 antagonist, IFN-γ and IL-13 induced inflammationMA BING·Filed 2011·Granted Jul 17, 2012·0 cites·9 claims
- 3150US2013035290A1Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney InjuryUNIV YALE·Filed 2012·Application pending·0 cites
- 3249US2016263183A1Methods for treating lung diseaseUNIV BROWN·Filed 2016·Application pending·0 cites
- 3349US2022213193A1Bispecific antibodies against chi3l1 and pd1 with enhanced t cell-mediated cytotoxic effects on tumor cellsUNIV BROWN·Filed 2020·Application pending·0 cites
- 3449US2021395377A1Methods and compositions relating to anti-chi3l1 antibody reagents for the treatment of fibrosisUNIV BROWN·Filed 2019·Application pending·0 cites
- 3549US2009155266A1Methods and Compositions Relating to Vascular Endothelial Growth Factor and TH2 Mediated Inflammatory DiseasesUNIV YALE·Filed 2005·Application pending·0 cites
- 3647US2010256085A1Toll-Like Receptor Agonist Regulation of VEGF-Induced Tissue ResponsesUNIV YALE·Filed 2007·Application pending·0 cites
- 3746US2010216865A1MicroRNA COMPOSITIONS IN THE TREATMENT OF VEGF-MEDIATED DISORDERSELIAS JACK A·Filed 2008·Application pending·0 cites
- 3843US2010247538A1IL-18 and Protein Kinase R Inhibition for the Treatment of COPDUNIV YALE·Filed 2008·Application pending·0 cites
- 3939US2016139149A1Chi3l1 for the detection and treatment of nonalcoholic steatohepatitisUNIV BROWN·Filed 2015·Application pending·0 cites
- 4038US2013156750A1Compositions and Methods for Using Human YKL-40 to Treat Acute Lung InjuryELIAS JACK A·Filed 2011·Application pending·0 cites
- 4137US2011245323A1RIG-Like Helicase Innate Immunity Inhibits VEGF-Induced Tissue ResponsesUNIV YALE·Filed 2011·Application pending·0 cites
- 4235US2016166520A1Methods and compositions relating to the treatment of visceral fat and asthmaUNIV YALE·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →